Meta's AI Investments Spark Debate Amid Earnings Disappointment

Strategic Insights -

Meta Platforms Inc's third-quarter earnings have been overshadowed by debate about the company's ramping investment in AI initiatives, with analysts at Wedbush, Jefferies, and Oppenheimer offering sharply differing takes on the company's long-term trajectory. The stock traded down 11.5% amid investor concerns about Meta's ballooning AI investments. Despite this, Wedbush remained upbeat, reaffirming its 'Outperform' rating and $920 price target, while Jefferies flagged investor sensitivity to Meta's growing capex. Oppenheimer took a more cautious stance, downgrading Meta to 'Hold' from 'Outperform' amid uncertainty around AI investments.

Key Takeaways:

  • Wedbush analysts considered Meta's AI investment "justified" due to the infusion of AI capabilities across the company's ad stack and content recommendation engines, driving tangible results.
  • The firm highlighted strong ad growth and a robust core business, noting Meta's potential to monetize its Meta AI assistant across multiple commercial use cases.
  • Jefferies maintained a constructive tone on Meta but flagged investor sensitivity to Meta's growing capex, describing the upcoming spending surge as a "pressure on margins."
  • Oppenheimer warned of "uncertainty around AI investments" and drew parallels to Meta's heavy 2021-2022 Metaverse spending, arguing that investors will struggle to rationalize the price-to-earnings ratio until visibility into 2027.
  • Meta's fiscal 2025 capex guidance of $70 billion to $72 billion "appeared conservative," according to Jefferies, but expect fiscal 2026 to be "notably higher."
  • Wedbush estimated Meta's spending on AI as "justified" and maintained a positive view on the company's risk-reward profile.

Statistics:

  • Meta shares traded down 11.5% - $665
  • Fiscal 2025 capex guidance: $70 billion to $72 billion
  • Fiscal 2026 capex expectations: "notably higher" than fiscal 2025
  • Oppenheimer's estimated price target for Meta: Not disclosed

Sources:

  • Wedbush

+ Analysts: Not specified

+ Publication date: Not specified

  • Jefferies

+ Analysts: Not specified

+ Publication date: Not specified

  • Oppenheimer

+ Analysts: Not specified

+ Publication date: Not specified